The only downside to all these indications with leronlimab is cannibalization. Not that it will matter if we get to that point, as simply having revenue from 22 solid tumor cancers likely competes or would be more than any other BP.

It would be a helluva marketing campaign or commercial by stating leronlimab can keep your cancer from spreading, boost your immune system, and help or possibly treat these other diseases with a sub-q injection weekly: Alzheimer's, Asthma, Atherosclerosis, Atopic Dermatitis, Cancer (other cancers), Coeliac Disease, Chronic Fatigue Syndrome, COPD, COVID-19 (and other corona viruses), Crohn's Disease, Colitis, Dermatomyositis, Diabetes (type 1), Duchenne Muscular Dystrophy (possibly other muscular dystrophys also), Emphysema, Fibromyalgia, Grave’s Disease, Guillain-Barre Syndrome, GVHD, Hashimoto’s Thyroiditis, Hepatitis (autoimmune), HIV, Idiopathic Pulmonary Fibrosis, Inflammatory Bowel Disease, Influenza (severe), Lambert-Eaton Syndrome, Lupus, Multiple Sclerosis, Myasthenia Gravis, Myocarditis, NASH, Neurofibromatosis, Parkinson's Disease, Pemphigus, Pneumonia, Polymyositis, Post-Myocardial Infarction Syndrome, Psoriasis, Rheumatic Fever, Rheumatoid Arthritis, Sarcoidosis, Scleroderma, Sickle Cell Disease (anti-inflammatory effect), Sjogren’s Syndrome, Stroke, Tuberculosis and Vasculitis.

Side effects may include redness and slight pain at the injection site for a few minutes